78. 下垂体前葉機能低下症 Hypopituitarism Clinical trials / Disease details

臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-001939-21-LV (EUCTR)	15/08/2016	31/05/2016	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 19.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Estonia;Morocco;Slovakia;Greece;Spain;Ukraine;Lebanon;Lithuania;Turkey;Russian Federa ...
2	EUCTR2015-001939-21-LT (EUCTR)	04/05/2016	29/02/2016	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 19.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Estonia;Morocco;Slovakia;Greece;Spain;Ukraine;Lebanon;Lithuania;Turkey;Russian Federa ...
3	EUCTR2015-001939-21-PL (EUCTR)	19/04/2016	18/01/2016	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 20.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	56	Phase 2	Belarus;Serbia;Estonia;Slovakia;Greece;Ukraine;Lebanon;Lithuania;Turkey;Russian Federation;Hungary;C ...
4	EUCTR2015-001939-21-EE (EUCTR)	30/03/2016	16/02/2016	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 19.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Estonia;Morocco;Slovakia;Greece;Spain;Ukraine;Lebanon;Lithuania;Turkey;Russian Federa ...
5	NCT03309891 (ClinicalTrials.gov)	January 18, 2016	5/9/2017	Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency	A Phase 2, Randomized, Open-label, Active Controlled, Dose Finding Study of Long-acting Hybrid Fc Fu ...	Growth Hormone Deficiency	Drug: GX-H9;Drug: Genotropin	Genexine, Inc.	NULL	Completed	3 Years	11 Years	All	56	Phase 2	Ukraine
6	EUCTR2015-001939-21-GR (EUCTR)	12/11/2015	13/10/2015	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 18.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Slovakia;Morocco;Greece;Spain;Ukraine;Lebanon;Turkey;Russian Federation;Egypt;Czech R ...
7	EUCTR2015-001939-21-SK (EUCTR)	22/10/2015	27/07/2015	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 18.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Estonia;Slovakia;Greece;Spain;Ukraine;Lebanon;Lithuania;Turkey;Russian Federation;Egy ...
8	EUCTR2015-001939-21-CZ (EUCTR)	14/10/2015	10/07/2015	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 18.0;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Estonia;Slovakia;Greece;Spain;Ukraine;Lebanon;Lithuania;Turkey;Russian Federation;Egy ...
9	EUCTR2015-001939-21-HU (EUCTR)	16/07/2015	22/05/2015	A clinical study in paediatric patients with growth hormone deficiency to assess safety, tolerabilit ...	A phase 2, randomized, open-label, active controlled, dose finding study of the long-acting hybrid F ...	Growth Hormone Deficiency (GHD) in pre-pubertal children MedDRA version: 19.1;Level: PT;Classificati ...	Product Name: GX-H9 INN or Proposed INN: none Other descriptive name: hGH -hyFc, recombinant human grow ...	Genexine, Inc.	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 2	Serbia;Belarus;Estonia;Slovakia;Greece;Ukraine;Lebanon;Turkey;Lithuania;Russian Federation;Hungary;C ...
10	EUCTR2014-002698-13-PL (EUCTR)	30/06/2015	22/05/2015	A clinical study in AGHD to assess safety, tolerability and efficacy of GX-H9	A randomized, active-controlled, multiple-dose, open-label study to evaluate the safety, tolerabilit ...	Adult Growth Hormone Deficiency (AGHD) MedDRA version: 18.1;Level: PT;Classification code 10056438;T ...	Product Name: GX-H9 INN or Proposed INN: N/A Other descriptive name: hGH -hyFc, recombinant human growt ...	Genexine, Inc	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 2	Serbia;France;Hungary;Slovakia;Greece;Poland;Germany;Korea, Republic of;Sweden

First Previous1 2Next Last